Month 2: The Peak Challenge Period Month 2 represents the most challenging phase of Retatrutide treatment
I think well eventually see that the total cost of care of those with obesity on GLP-1 drugs is substantially higher than the total cost of care of those who are obese who are not treated with these drugs
With individualized dosing and ongoing medical guidance, treatment is carefully adjusted to support comfort and minimize side effects throughout your journey
While Ozempic and Wegovy will be fairly similar since they are both Semaglutide GLP-1, Mounjaro differs slightly in that much higher doses are required for use as a weight loss medication and is the newest on the market of these options, but comes with almost the same risks and side effects
the point is that the branded-versus-compounded choice, not the brand's marketing, largely sets the medication portion of the bill
Rare but serious risks include pancreatitis, thyroid cancer (in animal studies), and gallbladder issues
